clinical trial · NCT03290950
A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma
Multiple Myelomadaratumumabcarfilzomiblenalidomidedexamethasonedexamethasone
brief summary
This is a study to test the safety and effectiveness of the study drug, daratumumab in combination with carfilzomib, lenalidomide and dexamethasone. The purpose of this study is to test whether giving daratumumab along with the other drugs (carfilzomib, lenalidomide and dexamethasone) is safe for patients.
started
Sep 25, 2017
primary completion
May 21, 2025
completion
Sep 1, 2026
last updated
May 29, 2026
official title
Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Newly-Diagnosed Multiple Myeloma: A Clinical and Correlative Phase II Study
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol